GlycoMimetics (NASDAQ:GLYC – Get Free Report)‘s stock had its “neutral” rating reiterated by research analysts at HC Wainwright in a research report issued to clients and investors on Monday, Benzinga reports. Several other equities analysts also recently issued reports on GLYC. StockNews.com downgraded shares of GlycoMimetics from a “hold” rating to a “sell” rating in […]
Related Keywords
United States , , Acuta Capital Partners , Glycomimetics Company Profile , Associates Inc , Glycomimetics Inc , Get Free Report , One Financial , Mimetics Stock Down , Glycomimetics Daily , Glycomimetics , Nasdaq Glyc , Glyc , Medical , Reiterated Rating , Hc Wainwright ,
comparemela.com © 2020. All Rights Reserved.